RESUMEN
Despite a high prevalence of HIV in patients with serious mental health disorders, there is little information in the literature regarding details of their HIV treatment. The objective of this paper is to assess factors associated with the success of HIV therapy in people with schizophrenia, schizoaffective, and bipolar disease. The methods used are retrospective, post-study chart review, and clinician questionnaire at two HIV county clinics. Forty-nine (4.8%) study patients were identified, 51% of whom achieved an undetectable HIV viral load. These patients tended to have less drug use (42% vs. 68%), more ongoing psychiatric visits (70% vs. 58%) and were more apt to take psychiatric medicines (70% vs. 40%) than patients with detectable HIV viral loads. Both groups had many missed appointments. We were surprised to find that many patients were successful with HIV treatment despite substance abuse, uncontrolled psychiatric symptoms, and lack of psychiatric care. Missing clinic appointments had little influence on treatment outcome.
Asunto(s)
Trastorno Bipolar/complicaciones , Centros Comunitarios de Salud , Infecciones por VIH/tratamiento farmacológico , Esquizofrenia/complicaciones , Atención Ambulatoria , California , Femenino , Infecciones por VIH/complicaciones , Humanos , Masculino , Auditoría Médica , Persona de Mediana Edad , Estudios RetrospectivosRESUMEN
BACKGROUND: Reducing substance use and unprotected sex by HIV-positive persons improves individual health status while decreasing the risk of HIV transmission. Despite recommendations that health care providers screen and counsel their HIV-positive patients for ongoing behavioral risks, it is unknown how to best provide "prevention with positives" in clinical settings. Positive Choice, an interactive, patient-tailored computer program, was developed in the United States to improve clinic-based assessment and counseling for risky behaviors. METHODOLOGY AND FINDINGS: We conducted a parallel groups randomized controlled trial (December 2003-September 2006) at 5 San Francisco area outpatient HIV clinics. Eligible patients (HIV-positive English-speaking adults) completed an in-depth computerized risk assessment. Participants reporting substance use or sexual risks (n = 476) were randomized in stratified blocks. The intervention group received tailored risk-reduction counseling from a "Video Doctor" via laptop computer and a printed Educational Worksheet; providers received a Cueing Sheet on reported risks. Compared with control, fewer intervention participants reported continuing illicit drug use (RR 0.81, 95% CI: 0.689, 0.957, p = 0.014 at 3 months; and RR 0.65, 95% CI: 0.540, 0.785, p<0.001 at 6 months) and unprotected sex (RR 0.88, 95% CI: 0.773, 0.993, p = 0.039 at 3 months; and RR 0.80, 95% CI: 0.686, 0.941, p = 0.007 at 6 months). Intervention participants reported fewer mean days of ongoing illicit drug use (-4.0 days vs. -1.3 days, p = 0.346, at 3 months; and -4.7 days vs. -0.7 days, p = 0.130, at 6 months) than did controls, and had fewer casual sex partners at (-2.3 vs. -1.4, p = 0.461, at 3 months; and -2.7 vs. -0.6, p = 0.042, at 6 months). CONCLUSIONS: The Positive Choice intervention achieved significant cessation of illicit drug use and unprotected sex at the group-level, and modest individual-level reductions in days of ongoing drug use and number of casual sex partners compared with the control group. Positive Choice, including Video Doctor counseling, is an efficacious and appropriate adjunct to risk-reduction efforts in outpatient settings, and holds promise as a public health HIV intervention. TRIAL REGISTRATION: Clinicaltrials.gov NCT00447707.
Asunto(s)
Consejo , Seropositividad para VIH/complicaciones , Pacientes Ambulatorios , Educación del Paciente como Asunto , Conducta de Reducción del Riesgo , Trastornos Relacionados con Sustancias/prevención & control , Sexo Inseguro/prevención & control , Adulto , Demografía , Femenino , Estudios de Seguimiento , Seropositividad para VIH/psicología , Humanos , Masculino , Medición de Riesgo , Programas Informáticos , Trastornos Relacionados con Sustancias/complicacionesRESUMEN
Federal HIV prevention strategy seeks to increase efforts by health care providers to identify and reduce their HIV-positive patients' transmission-related behaviors. Implementation of these recommendations will be hindered if providers perceive these efforts have the potential to harm their relationships with patients. Because transmission-related behaviors (unsafe sex and sharing needles) and the related issues of drug and alcohol use also jeopardize the health of HIV-positive patients, providers can use patient-centered counseling when addressing those behaviors. We suggest efforts to increase provider-delivered transmission-prevention counseling be reframed so that "prevention with positives" includes the goal of protecting HIV-positive patients' health. We review the specific consequences of these risky behaviors on HIV-positive patients' health and review brief counseling strategies appropriate for HIV care providers.
Asunto(s)
Consejo/métodos , Infecciones por VIH/prevención & control , Seropositividad para VIH , Personal de Salud , Promoción de la Salud , Infecciones por VIH/transmisión , Humanos , Educación del Paciente como Asunto , Conducta de Reducción del Riesgo , Asunción de RiesgosRESUMEN
In the United States, one-third of human immunodeficiency virus (HIV)-infected patients are also coinfected with hepatitis C virus (HCV). Of 228 coinfected patients whose charts were reviewed in our 2000 study, only 2 had received therapy with interferon. To address low rates of treatment, in 2001 we implemented a program to shift the primary responsibility for oversight of care for HCV-infected patients from the liver clinic to HIV primary care clinicians and to provide education and support regarding adherence to patients. Critical elements of the program include education of HIV clinicians with regard to treatment for HCV infection, establishment of a coinfection clinic in the HIV clinic, assignment of a full-time Registered Nurse for monitoring and support of patients undergoing treatment for HCV infection, and development of a weekly peer group for the coinfected patients. Preliminary treatment results for patients in the program suggest that this approach has promise for improving outcomes of treatment among coinfected patients.
Asunto(s)
Prestación Integrada de Atención de Salud/organización & administración , Infecciones por VIH/terapia , Hepatitis C/terapia , Estudios de Cohortes , Atención a la Salud/normas , Educación Médica Continua , Grupos Focales , Infecciones por VIH/complicaciones , Hepatitis C/complicaciones , Humanos , Enfermeras Clínicas , Servicio Ambulatorio en Hospital/organización & administración , Educación del Paciente como Asunto , Estudios Retrospectivos , Grupos de Autoayuda , Resultado del TratamientoRESUMEN
Liver disease associated with hepatitis C virus (HCV) is a significant and increasing cause of death for HIV-infected patients, but limited data exist to guide treatment of coinfection. Increased knowledge of HCV disease and its treatment among HIV care practitioners and adoption of routine care procedures can improve management of coinfected patients. This article discusses HCV screening and diagnosis, counseling and health care maintenance, and evaluation for and supervision of treatment in HIV-seropositive patients who are coinfected with HCV. The experiences of the Oakland, California-based Alameda County Medical Center, which treats more than 200 coinfected patients, are detailed and serve as the basis for suggested management strategies. This article summarizes a presentation given by Kathleen A. Clanon, MD at the November 2002 International AIDS Society-USA course in San Diego.